Page last updated: 2024-08-21

treosulfan and Leukemia

treosulfan has been researched along with Leukemia in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19904 (28.57)18.7374
1990's1 (7.14)18.2507
2000's5 (35.71)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boysen, G; Danylesko, I; Nagler, A; Shimoni, A; Varda-Bloom, N1
Boztug, H; Cant, A; Glogova, E; Lankester, A; Peters, C; Pötschger, U; Skinner, R; Slatter, M; Sykora, KW; Veys, P; Wachowiak, J; Zecca, M1
Bilska, K; Prost, M; Raciborska, A; Rodriguez-Galindo, C; Rychlowska-Pruszynska, M; Ussowicz, M1
Danylesko, I; Nagler, A; Shimoni, A1
Casper, J; Dölken, G; Freund, M; Hammer, U; Hartung, G; Kiefer, T; Kleine, HD; Knauf, W; Knopp, A; Steiner, B; Wegener, R; Wilhelm, S; Wolff, D1
LOEB, V1
Aschan, J; Blau, I; Casper, J; Doelken, G; Freund, M; Giebel, S; Holowiecki, J; Knauf, W; Kroger, N; Ruutu, T; Schafer-Eckart, K; Volin, L; Wandt, H; Zander, A1
Baumgart, J; Beelen, DW; Hilger, RA; Scheulen, ME; Seeber, S; Strumberg, D; Trenschel, R1
Boos, J; Bremer, A; Dirksen, U; Jürgens, H; Lanvers-Kaminsky, C1
Esser, R; Kalaäoui, RE; Klingebiel, T; Kloess, S; Koehl, U; Kreuter, J; Lehrnbecher, T; Munkelt, D; Schubert, R; Schwabe, D; Wehner, S; Zimmermann, SY1
Ernst, P; Ersbøl, J; Hou-Jensen, K; Knudtzon, S; Larsen, MS; Nissen, NI; Pedersen-Bjergaard, J; Rose, C; Sørensen, HM1
Bell, J; Clarke, EA; Day, NE; Høst, H; Kaldor, JM; Karjalainen, S; Mehnert, W; Pedersen, D; Pettersson, F; Prior, P1
Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM1

Reviews

1 review(s) available for treosulfan and Leukemia

ArticleYear
Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.
    Bone marrow transplantation, 2012, Volume: 47, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Busulfan; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Myelodysplastic Syndromes; Survival Rate; Transplantation Conditioning; Transplantation, Homologous

2012

Trials

3 trial(s) available for treosulfan and Leukemia

ArticleYear
Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation.
    Blood, 2004, Jan-15, Volume: 103, Issue:2

    Topics: Acute Disease; Adult; Aged; Alkylating Agents; Busulfan; Chronic Disease; Family; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2004
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.
    Annals of hematology, 2004, Volume: 83 Suppl 1

    Topics: Busulfan; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukocyte Transfusion; Lymphoma; Myelodysplastic Syndromes; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2004
Leukemia following chemotherapy for ovarian cancer.
    The New England journal of medicine, 1990, Jan-04, Volume: 322, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Case-Control Studies; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Leukemia; Melphalan; Multicenter Studies as Topic; Neoplasms, Multiple Primary; Ovarian Neoplasms; Registries; Risk Factors; Thiotepa

1990

Other Studies

10 other study(ies) available for treosulfan and Leukemia

ArticleYear
A simplified method for detection of N-terminal valine adducts in patients receiving treosulfan.
    Rapid communications in mass spectrometry : RCM, 2019, Nov-15, Volume: 33, Issue:21

    Topics: Adult; Aged; Busulfan; Chromatography, Liquid; Female; Hemoglobins; Humans; Leukemia; Lymphoma; Male; Middle Aged; Stem Cell Transplantation; Tandem Mass Spectrometry; Transplantation Conditioning; Transplantation, Homologous; Valine; Young Adult

2019
European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Blood Transfusion; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Europe; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Male; Multivariate Analysis; Retrospective Studies; Societies, Medical; Transplantation Conditioning; Treatment Outcome; Vidarabine

2016
Effective treatment of cytomegalovirus retinitis and neuritis with retrobulbar ganciclovir after treosulfan-based autologous bone marrow transplant.
    Klinika oczna, 2015, Volume: 117, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Busulfan; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Infant; Leukemia; Retinitis; Treatment Outcome

2015
DIHYDROXYBUSULFAN (NSC-39069) IN CHRONIC MYELOCYTIC LEUKEMIA AND MISCELLANEOUS MALIGNANT NEOPLASMS.
    Cancer chemotherapy reports, 1964, Volume: 42

    Topics: Busulfan; Drug Therapy; Geriatrics; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Neoplasms; Toxicology

1964
Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantation.
    International journal of clinical pharmacology and therapeutics, 2004, Volume: 42, Issue:11

    Topics: Antineoplastic Agents, Alkylating; Area Under Curve; Busulfan; Cyclophosphamide; Half-Life; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Metabolic Clearance Rate; Myeloablative Agonists; Tissue Distribution; Transplantation Conditioning

2004
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
    Anti-cancer drugs, 2006, Volume: 17, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Bone Neoplasms; Busulfan; Cell Survival; Humans; Leukemia; Neuroblastoma; Osteosarcoma; Sarcoma, Ewing; Tumor Cells, Cultured

2006
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.
    Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Busulfan; Caspase 3; Cell Line, Tumor; Child; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia; Stem Cells; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Vidarabine

2008
Treosulphan.
    IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, 1981, Volume: 26

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Busulfan; Carcinogens; Chemical Phenomena; Chemistry; Humans; Leukemia; Mutagenicity Tests; Rats

1981
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).
    Cancer, 1980, Jan-01, Volume: 45, Issue:1

    Topics: Adult; Aged; Busulfan; Chromosome Aberrations; Female; Humans; Leukemia; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Risk; Time Factors

1980
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Annals of internal medicine, 1985, Volume: 103, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Leukemia; Lymphoma; Male; Mechlorethamine; Middle Aged; Myeloproliferative Disorders; Nitrosourea Compounds; Ovarian Neoplasms; Preleukemia; Risk; Time Factors

1985